HomeReleasesScottish Rite for Children Retains Top National Or...
Releases

Scottish Rite for Children Retains Top National Orthopedic Ranking

Scottish Rite for Children Retains Top National Orthopedic Ranking

For the second consecutive year, U.S. News & World Report has named Scottish Rite for Children the nation's premier destination for pediatric orthopedic care. The Dallas-based institution secured the top spot in the 2026-2027 rankings, marking a historic streak for a facility long recognized for its specialized medical expertise.

The annual rankings, compiled in partnership with RTI International, evaluate hospitals based on clinical outcomes, adherence to best practices, and the quality of resources dedicated to patient care. This year’s distinction follows nearly two decades of consistent placement among the country’s elite programs, achieved through a collaborative model with Children’s Medical Center Dallas and UT Southwestern Medical Center.

Robert L. Walker, president and CEO of Scottish Rite, credited the achievement to the collective efforts of the hospital’s staff. Beyond clinical excellence, the organization is actively pushing the boundaries of treatment. Recent milestones include the first U.S. implantation of an FDA-cleared device for early-onset scoliosis and the receipt of $4.1 million in National Institutes of Health grants to study osteonecrosis. The hospital also continues to shape the next generation of specialists, having recently graduated the 200th fellow from the Dorothy & Bryant Edwards Fellowship in Pediatric Orthopedics and Scoliosis.

Chief of Staff Daniel J. Sucato, M.D., emphasized that these advancements remain rooted in a singular focus on individual patient needs. By integrating clinical practice, research, and global education, the institution maintains its mission to treat complex spinal and orthopedic conditions while operating as a child-friendly environment that serves patients regardless of their family’s financial circumstances.

Share:TelegramXFacebook

Read Also

Comments (0)

Leave a comment

No comments yet. Be the first!